Litigation Details for Roxane Laboratories, Inc. v. Camber Pharmaceuticals Inc. (Fed. Cir. 2014)
✉ Email this page to a colleague
Roxane Laboratories, Inc. v. Camber Pharmaceuticals Inc. (Fed. Cir. 2014)
Docket | ⤷ Sign Up | Date Filed | 2014-09-09 |
Court | Court of Appeals for the Federal Circuit | Date Terminated | |
Cause | Assigned To | ||
Jury Demand | Referred To | ||
Patents | 6,576,665; 6,875,445 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Roxane Laboratories, Inc. v. Camber Pharmaceuticals Inc.
Details for Roxane Laboratories, Inc. v. Camber Pharmaceuticals Inc. (Fed. Cir. 2014)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2014-10-23 | 23 | U.S. Pat. Nos. 6,576,665 and mixing to form a second blend; 6,875,445. These patents also relate … 6,576,665 82 6/2003 Dennett, Jr. et al. …infringement of claims 1-6 of its U.S. Patent No. 8,563,032 (“’032 patent”), which is directed to novel pharmaceutical… C. U.S. Patent No. 8,563,032 Roxane is the owner of the ’032 patent, which is directed…capsules. Roxane owns U.S. Patent No. 8,563,032 (the '"032 patent"), directed to a pharmaceutical | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |